Atlas Trials

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma

Clinical trial NCT02303899 · COMPLETED

Trial details

NCT number
NCT02303899
Sponsor
Istituto Clinico Humanitas
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mesothelioma, Malignant
Start date
2014-11-01
Primary completion
2015-12-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.